Clinical Trial News and Research

RSS

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized.

10 Sep 2019

NIAID experts call for innovative research on STIs

Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day.

10 Sep 2019

Lilly launches new report highlighting challenges and opportunities of health care revolution

Eli Lilly and Company today calls on industry, academia and the NHS to do more to foster collaboration to ensure the UK maintains its global leadership position at the forefront of medicines research and discovery.

9 Sep 2019

IASLC highlights importance of tobacco cessation after cancer diagnosis

The International Association for the Study of Lung Cancer today used the platform of its largest international meeting to call attention to the importance of tobacco cessation after cancer diagnosis, and urged all physicians to screen cancer patients for tobacco use and recommend tobacco cessation.

8 Sep 2019

UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.

6 Sep 2019

Study confirms effectiveness of a combination therapy for advanced liver cancer

Liver cancer affects hundreds of thousands of people annually, and there are few viable therapies for the advanced stages of its most common form--hepatocellular carcinoma.

6 Sep 2019

Cancer patients with low income and no insurance see fewer trial benefits

When it comes to benefiting from experimental treatments offered in cancer clinical trials, your health insurance status and where you live matters, according to results of two new research studies to be presented at the 2019 ASCO Quality Care Symposium, held September 6 and 7 in San Diego.

5 Sep 2019

ASTRO guideline provides recommendations on use of radiation therapy to treat pancreatic cancer

A new clinical guideline from the American Society for Radiation Oncology provides recommendations on the use of radiation therapy to treat patients diagnosed with pancreatic cancer, including when radiation treatments are appropriate, as well as the optimal dosing, timing and fractionation for these treatments.

4 Sep 2019

NIH trial aims to improve drug discovery for ischemic stroke

The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.

4 Sep 2019

Drug developed to treat metastatic pancreatic cancer may help prolong life

A drug developed by researchers at the Renaissance School of Medicine at Stony Brook University that targets enzymes involved in the development of pancreatic cancer cells is showing promise for improved treatment of metastatic pancreatic cancer.

4 Sep 2019

Sustained drop in cholesterol and blood pressure reduces lifetime risk of heart, circulatory diseases

Modest and sustained decreases in blood pressure and cholesterol levels reduces the lifetime risk of developing fatal heart and circulatory diseases, such as heart attack and stroke, according to research part-funded by the British Heart Foundation and supported by the National Institute for Health Research.

4 Sep 2019

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

Scientists at The University of Texas at Dallas have found evidence suggesting that resistance to the "hunger hormone" ghrelin in the brain is linked to the cognitive impairments and memory loss associated with Alzheimer's disease.

4 Sep 2019

Too much Vitamin D could be harmful to bones

Vitamin D – an essential for healthy bones and calcium in the body, is prepared by the body when the skin is exposed to sunlight. A daily exposure of around 10 to 15 days is considered to be adequate for fulfilling the needs of vitamin D in the body.

4 Sep 2019

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

3 Sep 2019

Mount Sinai researchers discover drug resistance signature in Crohn's disease

By mapping out more than 100,000 immune cells in patients with Crohn's disease, Mount Sinai researchers have discovered a signature of cells that are involved in a type of the disease that does not respond to treatment, according to a study published in Cell in August.

29 Aug 2019

Tanner Pharma Group to attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US conferences

Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several international healthcare conferences throughout the upcoming months of March and April.

From Tanner Pharma Group 29 Aug 2019

Investigational drug reduces stuttering symptoms in open-label pilot study

A team led by a psychiatrist at the University of California, Riverside, has tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing.

28 Aug 2019

Study addresses disability prevention for ethnic/racial minority and immigrant elders

A randomized controlled trial of a new disability prevention intervention, called Positive Minds-Strong Bodies, indicates that improving coping skills and physical strengthening can significantly improve functioning and mood in racial and ethnic minority and immigrant older adults.

28 Aug 2019

Gold nanoparticles used successfully in prostate tumour trial

Researchers at the Icahn School of Medicine, Mount Sinai, New York have reported a pilot clinical trial with a “nanoparticle-based photothermal cancer therapy” for prostate cancers. Their work with this targeted therapy is published in a study titled, “Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study,” in the latest issue of the journal Proceedings of National Academy of Science.

28 Aug 2019

Study reveals link between popular pain medication and greater risk of hypoglycemia

Since its approval in 1995, the opioid tramadol (marketed as ConZip and Ultram) has become a widely prescribed remedy for osteoarthritis and other painful indications, in part because it presents a lesser risk for some side effects and has a lower abuse potential when compared to other opioids.

28 Aug 2019

Clinical Trial News and Research

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

NIAID experts call for innovative research on STIs

Lilly launches new report highlighting challenges and opportunities of health care revolution

IASLC highlights importance of tobacco cessation after cancer diagnosis

UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

Study confirms effectiveness of a combination therapy for advanced liver cancer

Cancer patients with low income and no insurance see fewer trial benefits

ASTRO guideline provides recommendations on use of radiation therapy to treat pancreatic cancer

NIH trial aims to improve drug discovery for ischemic stroke

Drug developed to treat metastatic pancreatic cancer may help prolong life

Sustained drop in cholesterol and blood pressure reduces lifetime risk of heart, circulatory diseases

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

Too much Vitamin D could be harmful to bones

Ticagrelor reduces heart attacks and strokes for patients with diabetes

Mount Sinai researchers discover drug resistance signature in Crohn's disease

Tanner Pharma Group to attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US conferences

Investigational drug reduces stuttering symptoms in open-label pilot study

Study addresses disability prevention for ethnic/racial minority and immigrant elders

Gold nanoparticles used successfully in prostate tumour trial

Study reveals link between popular pain medication and greater risk of hypoglycemia

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer